Revenue
$124.61M
Fiscal year ended 2026-06-30Operating income
$9.15M
Fiscal year ended 2026-06-30Free cash flow
$3.12M
Fiscal year ended 2026-06-30Core Laboratories Inc. /DE/ (CLB) reported revenue of $124.61M and net income of $5.96M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Core Laboratories Inc. /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Oil & Gas Field Services, NEC.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124.61M | $121.80M | $138.26M | $134.52M | $130.16M | $123.58M | $129.24M | $134.40M | $130.58M | $129.64M |
| Cost of revenue | $101.37M | $102.07M | $109.52M | $104.90M | $103.70M | $99.47M | $106.20M | $106.80M | $102.93M | $104.59M |
| Gross profit | $23.24M | $19.72M | $28.74M | $29.62M | $26.46M | $24.12M | $23.04M | $27.59M | $27.65M | $25.05M |
| Operating income | $9.15M | $1.89M | $15.83M | $20.93M | $15.29M | $4.42M | $14.17M | $19.80M | $16.01M | $8.57M |
| Net income | $5.96M | -$789.00K | $4.95M | $14.24M | $10.64M | -$154.00K | $7.40M | $11.74M | $9.03M | $3.22M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 46.88M | shares 46.07M | Unavailable | shares 47.08M | shares 47.36M | shares 46.77M | Unavailable | shares 47.82M | shares 47.74M | shares 47.70M |
| Pretax income | $6.30M | -$1.00M | $13.22M | $18.28M | $12.58M | $1.82M | $11.54M | $16.70M | $12.80M | $5.15M |
| Income tax expense | $507.00K | -$251.00K | $8.09M | $3.75M | $1.91M | $1.75M | $4.08M | $4.69M | $3.61M | $1.66M |
| Diluted EPS | $0.13 | $-0.02 | Unavailable | $0.30 | $0.22 | $0.00 | Unavailable | $0.25 | $0.19 | $0.07 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $10.95M | $14.72M | $10.63M | $10.69M | $10.46M | $13.65M | $9.08M | $8.64M | $10.26M | $11.79M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $22.74M | $22.82M | $22.70M | $25.63M | $31.19M | $22.11M | $19.16M | $21.47M | $17.70M | $14.91M |
| Total assets | $586.78M | $587.73M | $584.01M | $591.36M | $596.84M | $586.24M | $585.13M | $600.47M | $597.80M | $597.80M |
| Current assets | $214.36M | $214.37M | $214.66M | $226.91M | $237.68M | $228.77M | $221.33M | $235.23M | $233.53M | $229.05M |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $101.05M | $104.73M | $106.02M | $95.74M | $104.77M | $103.73M | $102.44M | $94.94M | $97.60M | $85.47M |
| Total equity incl. NCI | $278.77M | $275.14M | $272.21M | $277.39M | $261.88M | $253.94M | $252.32M | $256.42M | $245.69M | $237.42M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $57.96M | $57.78M | $54.50M | $58.24M | $59.77M | $59.03M | $59.40M | $65.49M | $69.90M | $70.71M |
| Accounts receivable | $108.82M | $108.28M | $113.53M | $110.26M | $113.91M | $117.03M | $111.76M | $117.59M | $115.64M | $115.09M |
| Goodwill | $105.80M | $105.80M | $105.79M | $100.01M | $100.00M | $99.44M | $99.44M | $99.44M | $99.44M | $99.44M |
| Long-term debt | $113.86M | $114.46M | $110.26M | $114.10M | $124.61M | $124.37M | $126.11M | $139.87M | $147.62M | $160.37M |
| Accounts payable | $40.16M | $39.98M | $37.28M | $36.94M | $41.70M | $38.50M | $34.55M | $33.63M | $36.86M | $32.49M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.81M | $3.96M | $7.95M | $8.50M | $13.92M | $6.66M | $20.62M | $13.10M | $17.15M | $5.53M |
| Capital expenditures | $4.69M | $3.45M | $2.94M | $2.01M | $3.47M | $2.78M | $3.24M | $2.73M | $2.87M | $3.05M |
| Investing cash flow | -$3.93M | -$3.39M | -$3.75M | $2.39M | -$1.64M | $772.00K | -$3.56M | -$491.00K | -$687.00K | -$1.66M |
| Financing cash flow | -$3.96M | -$457.00K | -$7.12M | -$16.45M | -$3.20M | -$4.48M | -$19.37M | -$8.83M | -$13.68M | -$4.08M |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Stock-based compensation | $902.00K | $5.03M | $1.11M | $1.33M | $538.00K | $4.16M | -$458.00K | -$475.00K | -$132.00K | $4.82M |
| Common dividends paid | $460.00K | $460.00K | $466.00K | $465.00K | $469.00K | $469.00K | $469.00K | $469.00K | $470.00K | $468.00K |
| Common share repurchases | $2.69M | $4.00M | $2.66M | $5.01M | $2.74M | $2.02M | $4.90M | $196.00K | $162.00K | $44.00K |
| Depreciation & amortization | $3.82M | $3.76M | $3.67M | $3.59M | $3.67M | $3.72M | $3.66M | $3.68M | $3.77M | $3.84M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $3.12M | $517.00K | $5.00M | $6.50M | $10.45M | $3.88M | $17.37M | $10.37M | $14.28M | $2.48M |
| Gross margin | 18.6% | 16.2% | 20.8% | 22.0% | 20.3% | 19.5% | 17.8% | 20.5% | 21.2% | 19.3% |
| Operating margin | 7.3% | 1.5% | 11.5% | 15.6% | 11.7% | 3.6% | 11.0% | 14.7% | 12.3% | 6.6% |
| FCF margin | 2.5% | 0.4% | 3.6% | 4.8% | 8.0% | 3.1% | 13.4% | 7.7% | 10.9% | 1.9% |
| SBC / revenue | 0.7% | 4.1% | 0.8% | 1.0% | 0.4% | 3.4% | -0.4% | -0.4% | -0.1% | 3.7% |
| Current ratio | 2.12x | 2.05x | 2.02x | 2.37x | 2.27x | 2.21x | 2.16x | 2.48x | 2.39x | 2.68x |
| Revenue YoY growth | -4.3% | -1.4% | 7.0% | 0.1% | -0.3% | -4.7% | 0.8% | 7.2% | 2.1% | 1.0% |
| Net margin | 4.8% | -0.6% | 3.6% | 10.6% | 8.2% | -0.1% | 5.7% | 8.7% | 6.9% | 2.5% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 3.8% | 2.8% | 2.1% | 1.5% | 2.7% | 2.3% | 2.5% | 2.0% | 2.2% | 2.4% |
| Long-term debt / equity | 0.41x | Unavailable | 0.41x | 0.41x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 8.0% | Unavailable | 61.2% | 20.5% | 15.2% | 96.2% | 35.3% | 28.1% | 28.2% | 32.2% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CLB in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-03-23View SEC filing
10-Q · Filed 2025-10-23View SEC filing
10-Q · Filed 2025-07-25View SEC filing
10-Q · Filed 2025-04-28View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.